ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 105 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $154,447,000 | -49.3% | 2,889,546 | +7.1% | 0.01% | -50.0% |
| Q4 2015 | $304,735,000 | -68.9% | 2,697,484 | -81.4% | 0.02% | -45.9% |
| Q3 2015 | $979,666,000 | +418.6% | 14,487,141 | +493.8% | 0.04% | +184.6% |
| Q2 2015 | $188,902,000 | +42.0% | 2,439,661 | +6.1% | 0.01% | +44.4% |
| Q1 2015 | $133,030,000 | +138.8% | 2,299,550 | +33.1% | 0.01% | +125.0% |
| Q4 2014 | $55,716,000 | +103.0% | 1,727,640 | +54.0% | 0.00% | +100.0% |
| Q3 2014 | $27,447,000 | +64.5% | 1,121,654 | +19.2% | 0.00% | +100.0% |
| Q2 2014 | $16,684,000 | -7.1% | 941,003 | +4.8% | 0.00% | -50.0% |
| Q1 2014 | $17,963,000 | +43.6% | 897,716 | +20.5% | 0.00% | +100.0% |
| Q4 2013 | $12,506,000 | +68.1% | 745,240 | +6.4% | 0.00% | 0.0% |
| Q3 2013 | $7,440,000 | +90.5% | 700,551 | +0.3% | 0.00% | – |
| Q2 2013 | $3,905,000 | – | 698,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |